Dan Newhouse bought Amphenol Corporation (NYSE: APH)
Dan Newhouse (R-WA), a U.S. Representative, has disclosed 1 trade in Amphenol Corporation (APH) since 2026, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Dan Newhouse bought $1,001 - $15,000 of Amphenol Corporation (NYSE: APH) on July 10, 2026. Since that trade, APH is down -0.18% against the S&P 500 up +1.45%, an outperformance of -1.63%.
Data updated
Dan Newhouse's APH trades vs the price
APH is down -0.18% since Dan Newhouse bought on July 10, 2026, versus +1.45% for the S&P 500.
Performance since this trade
All Dan Newhouse APH trades
Dan Newhouse & APH trading FAQ
Is it legal for Dan Newhouse to trade Amphenol Corporation (APH) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Amphenol Corporation (APH), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Dan Newhouse buy APH?
Dan Newhouse disclosed a purchase of $1,001 - $15,000 of Amphenol Corporation (APH) on July 10, 2026, according to public STOCK Act filings.
How has APH performed since Dan Newhouse's trade?
Since Dan Newhouse bought APH on July 10, 2026, the stock is down -0.18%, versus +1.45% for the S&P 500 over the same period, an outperformance of -1.63%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional APH trades?
Quantellect tracks every disclosed congressional trade in Amphenol Corporation (APH) on the Amphenol Corporation congressional trading page, which aggregates filings across all members of Congress.
Dan Newhouse's APH tradesAll congressional filings for Amphenol CorporationDan Newhouse's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.